Filing Details
- Accession Number:
- 0001209191-17-022294
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-22 16:15:28
- Reporting Period:
- 2017-03-13
- Filing Date:
- 2017-03-22
- Accepted Time:
- 2017-03-22 16:15:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1640522 | G. Steven Brodie | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | President, Pharma Services | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-03-13 | 16,550 | $8.00 | 49,403 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-03-20 | 33,450 | $7.90 | 15,953 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $3.76 | 2014-04-16 | 2018-04-16 | 10,000 | 10,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $3.45 | 2015-03-05 | 2019-03-05 | 20,000 | 20,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $4.78 | 2016-05-04 | 2020-05-04 | 120,000 | 120,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $7.15 | 2017-04-20 | 2021-04-20 | 100,000 | 100,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2018-04-16 | 10,000 | 10,000 | Direct |
2019-03-05 | 20,000 | 20,000 | Direct |
2020-05-04 | 120,000 | 120,000 | Direct |
2021-04-20 | 100,000 | 100,000 | Direct |
Footnotes
- This line is included for purposes of amending the filing on 3/17/2017 which inadvertently showed the transaction as securities acquired rather than securities disposed of.
- On April 16, 2013 Dr. Brodie was granted 10,000 stock options. These options will vest ratably over the next three anniversary dates of the grant dates.
- On March 5, 2014 Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
- On May 4, 2015 Dr, Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- On April 20, 2016, Mr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.